BR0209882A - Método para o tratamento de distúrbios de olho seco - Google Patents

Método para o tratamento de distúrbios de olho seco

Info

Publication number
BR0209882A
BR0209882A BR0209882-2A BR0209882A BR0209882A BR 0209882 A BR0209882 A BR 0209882A BR 0209882 A BR0209882 A BR 0209882A BR 0209882 A BR0209882 A BR 0209882A
Authority
BR
Brazil
Prior art keywords
dry eye
eye disorders
treating dry
disorders
treating
Prior art date
Application number
BR0209882-2A
Other languages
English (en)
Inventor
John M Yanni
Daniel A Gamache
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0209882A publication Critical patent/BR0209882A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Abstract

"MéTODO PARA O TRATAMENTO DE DISTúRBIOS DE OLHO SECO". A 22,29-epóxi-3,4,6,7,29-pentaidróxi-, (3<244>,4<225>,5<244>,6<244>,7<225>,14<225>,22S)-estigmast an-15-ona é útil para o tratamento dos distúrbios de olho seco e de outros distúrbios que requerem o umedecimento dos olhos.
BR0209882-2A 2001-05-21 2002-05-17 Método para o tratamento de distúrbios de olho seco BR0209882A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29250001P 2001-05-21 2001-05-21
PCT/US2002/015784 WO2002094284A1 (en) 2001-05-21 2002-05-17 Method of treating dry eye disorders

Publications (1)

Publication Number Publication Date
BR0209882A true BR0209882A (pt) 2004-06-08

Family

ID=23124938

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209882-2A BR0209882A (pt) 2001-05-21 2002-05-17 Método para o tratamento de distúrbios de olho seco

Country Status (10)

Country Link
US (1) US20030008853A1 (pt)
EP (1) EP1392322A1 (pt)
JP (1) JP2004531560A (pt)
CN (1) CN1239161C (pt)
BR (1) BR0209882A (pt)
CA (1) CA2447918A1 (pt)
MX (1) MXPA03010633A (pt)
PL (1) PL367097A1 (pt)
WO (1) WO2002094284A1 (pt)
ZA (1) ZA200308770B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094836A2 (en) 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
CN103285026B (zh) * 2006-05-19 2017-08-04 箭头研究公司 肿瘤坏死因子α相关状况的RNAi介导的抑制
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US527851A (en) * 1894-10-23 Process of reducing aluminium
US3991759A (en) * 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
EP0459148B1 (en) * 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
DE69212850T2 (de) * 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
ES2139005T3 (es) * 1992-04-21 2000-02-01 Schepens Eye Res Inst Terapia ocular con androgeno en el sindrome de sjogren.
US6107289A (en) * 1992-04-21 2000-08-22 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
US5506221A (en) * 1992-12-24 1996-04-09 University Of British Columbia Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
AU2792997A (en) * 1997-05-26 1998-12-30 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
US6096733A (en) * 1998-12-10 2000-08-01 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
CA2444696A1 (en) * 2001-04-19 2002-10-31 Bristol-Myers Squibb Company Polynucleotides and polypeptides associated with the nf-kb pathway
US20040076691A1 (en) * 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations

Also Published As

Publication number Publication date
CA2447918A1 (en) 2002-11-28
MXPA03010633A (es) 2004-03-09
US20030008853A1 (en) 2003-01-09
CN1509177A (zh) 2004-06-30
ZA200308770B (en) 2004-11-23
CN1239161C (zh) 2006-02-01
EP1392322A1 (en) 2004-03-03
PL367097A1 (en) 2005-02-21
JP2004531560A (ja) 2004-10-14
WO2002094284A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
BR9402201A (pt) Solução oftálmica e método para tratar o olho contra irritação e secura
WO2000038786A3 (en) Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
BR9908870A (pt) Processos para regularizarem a aparência da pele
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
BR9201154A (pt) Processo mpr para o tratamento de oleos glicerideos,produtos quimicos graxos e ceras de esteres
BR9913831A (pt) Processo para tratamento de arteriosclerose empregando um inibidor de ap2 e combinação
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
PT867178E (pt) Utilizacao de agonistas nao alostericos de gaba para o tratamento de desordens do sono
BR0015392A (pt) Lipoxina a4 e seus análogos para o tratamento de olho ressecado
PT1228032E (pt) Composicoes contendo derivados do acido hidroxieicosatetraenoico e metodos de utilizacao para o tratamento de desordens do olho seco
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ES2060918T3 (es) Derivados de ciclopropilo que poseen actividad inhibidora lipoxigenasa.
EP1383529A4 (en) METHOD FOR THE TREATMENT OF EYES AND SQUATING TISSUES WITH THYMOSINE 4 (T 4), ANALOGUE, ISOFORMS AND OTHER DERIVATIVES
BR0209882A (pt) Método para o tratamento de distúrbios de olho seco
BR0211476A (pt) Utilização de um material à base de fibras orgânicas e/ou inorgânicas e de chitosan para a fixação de ìons metálicos
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
EP0938898A3 (en) Treatment of pruritus
BRPI0409416A (pt) processo para o tratamento de superfìcies de papel, papel, e, usos de um papel, e de uma dispersão aquosa
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
BR9606925A (pt) Utilização de compostos e processo para o tratamento e profilaxia da obesidade
BR0015402A (pt) Derivados de ácido 15-hidroxieicosatetraenóico de cadeia Èmega modificada e métodos de seu uso para o tratamento de olho seco
NO20012777D0 (no) Anvendelse av riluzol ved behandling av akustiske traumer
BR0209965A (pt) Uso de inibidores de nf-kappab para tratar distúrbios do olho seco
BR0113130A (pt) Processo para a preparação de um composto, compostos, e, processo para a preparação de fitona e/ou vitamina e

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8AE 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.